Edition:
United States

Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

9.06USD
2 Dec 2016
Change (% chg)

$-0.07 (-0.77%)
Prev Close
$9.13
Open
$9.13
Day's High
$9.19
Day's Low
$9.05
Volume
49,325
Avg. Vol
98,223
52-wk High
$9.58
52-wk Low
$5.50

NEO.OQ

Chart for NEO.OQ

About

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. Its Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The Company offers testing services, which includes... (more)

Overall

Beta: 1.08
Market Cap(Mil.): $716.04
Shares Outstanding(Mil.): 78.51
Dividend: --
Yield (%): --

Financials

  NEO.OQ Industry Sector
P/E (TTM): -- 37.86 29.87
EPS (TTM): -0.24 -- --
ROI: -0.50 8.96 14.95
ROE: -13.55 12.46 16.29

BRIEF-Neogenomics reports 142% revenue growth to $60.8 million and $9.6 million in cash flow from operations in the third quarter of 2016

* Neogenomics reports 142% revenue growth to $60.8 million and a record $9.6 million in cash flow from operations in the third quarter of 2016

Oct 26 2016

BRIEF-NeoGenomics Q2 adjusted earnings per share $0.04

* Neogenomics reports 159% revenue growth to $63.1 million and strong gains in profitability in the second quarter of 2016

Jul 26 2016

BRIEF-Neogenomics files for stock shelf of up to $200 mln

* Files for stock shelf of up to $200 million - SEC filing Source text -http://1.usa.gov/24WtPQB Further company coverage:

Jun 17 2016

Earnings vs. Estimates